[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349082-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349082-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-literature-review-of-interleukins-in-the-development-and-treatment-of-breast-cancer","A Literature Review of Interleukins in the Development and Treatment of Breast Cancer","","Breast cancer is the most common malignant tumor in women worldwide, and triple-negative disease shows the poorest prognosis because current therapies remain insufficient. This review connects inflammatory signaling with tumor development, focusing on interleukins as cytokines that regulate immune and hematopoietic functions. It addresses major literature gaps: designations of interleukins vary, and only 41 are consistently described. Interleukins influence both locally advanced disease and distant bone metastases, with ongoing and failed trials guiding newer combination strategies along the inflammatory pathway.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-literature-review-of-interleukins-in-the-development-and-treatment-of-breast-cancer/349082/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-literature-review-of-interleukins-in-the-development-and-treatment-of-breast-cancer/349082.png","ImageObject",300,407,{"name":42,"@type":43},"นรินทร์","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are interleukins considered important in breast cancer biology?","Question",{"text":63,"@type":64},"Interleukins are cytokine-family protein molecules that participate in immune and hematopoietic system functions. The review describes them as elements influencing inflammatory processes related to cancer development.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many interleukins does the review focus on, and why?",{"text":68,"@type":64},"The review states that available literature consistently provides information on 41 interleukins. It is presented as the first review detailing all 41 and their effects on breast cancer development.",{"name":70,"@type":61,"acceptedAnswer":71},"What role do interleukins play in tumor progression according to the review?",{"text":72,"@type":64},"Interleukins affect both locally advanced breast cancer development and distant metastases, mainly to the bones. Clinical trials are mentioned as ongoing or previously unsuccessful in these areas.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349082,1791045570,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":97,"preview_urls":146},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","Review  \nA Literature Review of Interleukins in the Development and Treatment of Breast Cancer  \nWiktoria Kra´snicka 1,†, Natasza Rybak 1,†, Kalina Wójcik 1, Aniela Stasiak 1, Maja Białowa˛s 1, Kamila Grzegorczyk 1, Tomasz Kolenda 2,3, Julian Malicki 4, Andrzej Marszałek 5 and Marlena Janiczek-Polewska 4,6, *  \nAcademic Editor: Tamara Guli´c  \nReceived: 18 January 2026  \nRevised: 6 April 2026  \nAccepted: 7 April 2026  \nPublished: 12 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Faculty of Medicine, Poznan University of Medical Sciences, Fredry Street 10, 61-701 Poznan, Poland  \n2 Research and Implementation Unit, Greater Poland Cancer Center, Garbary Street 15, 61-866 Poznan, Poland  \n3 Microbiology Laboratory, Greater Poland Cancer Center, Garbary Street 15, 61-866 Poznan, Poland  \n4 Department of Electroradiology, Poznan University of Medical Sciences, Garbary Street 15, 61-866 Poznan, Poland  \n5 Department of Clinical Pathology, Poznan University of Medical Sciences and Greater Poland Cancer Center, Garbary Street 15, 61-866 Poznan, Poland  \n6 Department of Clinical Oncology, Greater Poland Cancer Center, Garbary Street 15, 61-866 Poznan, Poland  \n* [Correspondence: mjaniczek@ump.edu.pl](Correspondence: mjaniczek@ump.edu.pl)  \n† These authors contributed equally to this work.  \nAbstract  \nBreast cancer is the most common malignant tumor in women worldwide. Triple-negative cancers have the worst prognosis, due to the low effectiveness of current therapies. In recent years, research has been conducted on the relationship between inflammatory process and the development of malignant tumors, including breast cancer. One of the elements influencing the inflammatory process is interleukins. These are small protein molecules belonging to the cytokine family that participate in the function of the human immune and hematopoietic systems. Interleukins are still being studied, and this is an area with significant knowledge gaps. More than 60 cytokines have been designated as interleukins over time, but not all of these designations are consistently used or universally accepted. In the available literature, we have only found information on 41 . This is the first review to detail all 41 interleukins and their effects on breast cancer development. The review shows that interleukins affect the development of both locally advanced breast cancer and the development of distant metastases, mainly to the bones. Clinical trials are also underway in these areas: some have failed, and others are still ongoing. Due to the lack of success in the use of interleukins in the treatment of breast cancer, the latest strategies are based on combining several elements of the inflammatory process pathway occurring in breast cancer. This can probably bring us closer to therapeutic success in this area.  \nKeywords: breast cancer; interleukins; cytokines; inflammatory process; carcinogenesis  \n1. Introduction  \nBreast cancer is the most common cause of mortality among women diagnosed with cancer, but the number of deaths has declined in recent years, especially in Western populations, due to better screening techniques. Despite this, it remains the most commonly diagnosed cancer worldwide and the leading cancer in women (accounting for 24.5% of all cancers in women) [1,2] . In 2024, the estimated number of new breast cancer diagnosesin women was 310,720, which equates to 15.5% of all new cancer cases, while the number of breast cancer deaths was 42,250, representing 6.9% of all cancer deaths. Data collected  \nfrom 2018 to 2021 indicated that 13.1% of women will be diagnosed with breast cancer during their lifetime (excluding 2020 due to the COVID-19 pandemic) [3] . Breast cancer incidence rates vary geographically and among different ethnic groups. Caucasian, white, non-Hispanic White in","cbCaiilwN8JMmwez","https://ap.wps.com/l/cbCaiilwN8JMmwez","pdf",1919995,43,"English","# 1. Introduction\n# 2. Ductal non-invasive carcinoma (DCIS)\n# 3. Non-invasive lobular carcinoma (LCIS)","[{\"question\":\"Why are interleukins considered important in breast cancer biology?\",\"answer\":\"Interleukins are cytokine-family protein molecules that participate in immune and hematopoietic system functions. The review describes them as elements influencing inflammatory processes related to cancer development.\"},{\"question\":\"How many interleukins does the review focus on, and why?\",\"answer\":\"The review states that available literature consistently provides information on 41 interleukins. It is presented as the first review detailing all 41 and their effects on breast cancer development.\"},{\"question\":\"What role do interleukins play in tumor progression according to the review?\",\"answer\":\"Interleukins affect both locally advanced breast cancer development and distant metastases, mainly to the bones. Clinical trials are mentioned as ongoing or previously unsuccessful in these areas.\"}]","A Literature Review of Interleukins in the Development and Treatment of Breast Cancer | PDF",1790081540,108,[147,151,155,159,163],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfc39d449e3b4e2d407fd3326fa64dbe.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12b2f80a3f646649357cf30c1e866338.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c3fa257da55cab00804d02441880c9b.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/749234c0a124b157835c561568cc5695.webp",980,1385,{"page_no":97,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5fa32d853353018fdddada8c9bb02211.webp",979,1384]